Endocrinologia, diabetes y nutricionFemaleHumansMiddle AgedGastrointestinal AgentsGlucagon-Like Peptide 1
3, 2, 1! From GLP-2 to GLP-1 analog over a 10-year journey.
María Sara Tapia-Sanchiz, Miguel Antonio Sampedro-Núñez, Sara Jiménez-Blanco, Begoña Molina-Baena
Published: 202610.1016/j.endien.2025.501662
Abstract
Short bowel syndrome (SBS) represents one of the central conditions in clinical nutrition, with a complex and challenging management. Teduglutide, an analog of human glucagon-like peptide-2 (GLP-2), is the first approved long-term, non-symptomatic tr…
Preview only. Read the full abstract at the source